News and Announcements
Alcidion and Calvary Health Care Collaborate
- Published March 07, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Alcidion Group Limited (ASX:ALC) today announced that it has signed an agreement with the Little Company of Mary Health Care (LCMHC, ‘Calvary)’ to assist the organisation with streamlining clinical coding and patient data across their facilities.
KEY TAKEAWAYS:
- Calvary Health Care operates 15 Public and Private Hospitals, 15 Retirement and Aged Care Facilities;
- A national network of Community Care Centres across six States and Territories in Australia;
- Calvary’s strategy includes the innovative use of technology and services to support new models of care that are patient-centric and sustainable.
Ray Blight, CEO and Chairman of Alcidion Group Limited said “We are delighted that Calvary has selected Alcidion to assist them in identifying opportunities for innovation and service improvement. Calvary’s Data Lake will provide the evidence for innovation opportunities and this will help drive future service improvements”.
Dr. Robin Mann, National Chief of Innovation, who leads Calvary’s digital transformation; commented, “The Data Lake forms an integral part of our innovation strategy moving forward and I look forward to working with Alcidion over the coming months.”
Alcidion Group Limited (ASX:ALC) is a publicly listed, innovative health informatics company that specializes in clinical products that improve productivity, safety and efficiency. Alcidion’s solutions target key problems for Emergency Rooms, Inpatient Services and Outpatient Departments and are built upon a next generation health informatics platform.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
